CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980373793
- Phone
- 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- 10-Q Report Quarterly Report
- 4 Open-market sale President and CEO sold 11,418 shares at an average $14.65 ($167,246)
- 4 Open-market sale Director sold 26,000 shares at $14.47 ($376,282)
- 4 Open-market sale Chief Operating Officer sold 20,000 shares at $14.00 ($280,000)
- 4 Open-market sale Chief Operating Officer sold 9,565 shares at $13.00 ($124,345)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at $13.50 ($135,000)
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at an average $12.54 ($125,364)
- 4 Open-market sale Chief Operating Officer sold 10,435 shares at an average $13.06 ($136,263)
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement
- S-3 Offering Registration Statement
- 8-K Event Other events
- 8-K Event Other events
- 4 Open-market sale Chief Operating Officer sold 20,000 shares at $12.00 ($240,000)
Page 22 of 49 · 978 filings